BPAMU
UTHR icon

BTG Pactual Asset Management US’s United Therapeutics UTHR Stock Holding History

BTG Pactual Asset Management US’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
+675
New +$380K 0.02% 310

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

BTG Pactual Asset Management US's UTHR Position: Q2 2026 in Review

BTG Pactual Asset Management US opened a new position in United Therapeutics (UTHR) in Q2 2026: 675 shares worth $366K. The stake represents 0.02% of the portfolio and ranks #310 among its holdings.

875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • BTG Pactual Asset Management US held 675 shares of United Therapeutics worth $366K as of Q2 2026.
  • United Therapeutics was a new BTG Pactual Asset Management US position in Q2 2026.
  • United Therapeutics made up 0.02% of BTG Pactual Asset Management US's portfolio in Q2 2026, its #310 holding.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on BTG Pactual Asset Management US's 13F filing for Q2 2026, filed 14 Aug 2026.